Umbralisib (TGR-1202) hydrochloride是一种口服有效的PI3Kδ/CK1ε双抑制剂，对慢性淋巴细胞白血病（CLL）T细胞具有独特的免疫调节作用，可用于血液系统恶性肿瘤研究。

[1] Swaroop Vakkalankaa, et al. Inhibition of PI3Kδ kinase by a selective, small molecule inhibitor suppresses B-cell proliferation and leukemic cell growth.[2]Deng C, Lipstein MR, Scotto L, Jirau Serrano XO, Mangone MA, Li S, Vendome J, Hao Y, Xu X, Deng SX, Realubit RB, Tatonetti NP, Karan C, Lentzsch S, Fruman DA, Honig B, Landry DW, O'Connor OA. Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kδ and CK1ε in hematological malignancies. Blood. 2017 Jan 5;129(1):88-99. doi: 10.1182/blood-2016-08-731240. Epub 2016 Oct 26. PMID: 27784673; PMCID: PMC5216267.